A Review of Recent Advances in Knowledge About Methadone Maintenance Treatment

by Ineke van Beusekom, Martin Y. Iguchi


Download eBook for Free

FormatFile SizeNotes
PDF file 5.8 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.


Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback116 pages $15.00 $12.00 20% Web Discount

This report, which provides a knowledge base for the development of methadone maintenance treatment clinical guidelines in Switzerland, reviews the world-wide literature (except for Switzerland, which is the subject of a separate investigation) on such treatment and existing guidelines. Articles on methadone maintenance treatment and concurring treatment modalities are discussed in detail, as well as existing knowledge about specific populations, such as pregnant addicts and addicts with HIV or tuberculosis. Research on prognostic factors to patients' responses to treatment and perceptions of opiate dependent persons are also reviewed to ascertain their value to practitioners in managing methadone maintenance treatment and in assessing the best possible treatment. A final chapter describes other substitution treatments in comparison to methadone maintenance and synthesizes the information of the review into a structured information source for thinking about guideline development.

Table of Contents

  • Chapter One


  • Chapter Two

    Study Design

  • Chapter Three

    Guidelines and Clinical Practice Recommendations

  • Chapter Four

    Methadone - Characteristics of the Drug

  • Chapter Five

    Treatment Outcome Studies

  • Chapter Six

    Special Populations

  • Chapter Seven

    Studies Describing Psychosocial and Other Non-Pharmacological Aspects of Treatment

  • Chapter Eight

    Perceptions of Addicts of Methadone Maintenance Treatment

  • Chapter Nine

    Methadone Maintenance Treatment As Compared to Other Substitution Treatments

  • Chapter Ten

    Conclusions: Recommendations for Guideline Development

Research conducted by

The research described in this report was performed within RAND Europe and RAND's Drug Policy Research Center.

This report is part of the RAND Corporation Monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.